Feedback / Questions
PRTH-101 - Incendia Therap
https://www.businesswire.com/news/home/20240910322002/en/Incendia-Therapeutics-Enrolls-First-Patient-in-Phase-1c-Clinical-Trial-of-PRTH-101-a-Novel-DDR1-Inhibitor
Sep 10, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next